Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Bio Key International (BKYI) Net Cash Flow (2016 - 2025)

Bio Key International (BKYI) has disclosed Net Cash Flow for 16 consecutive years, with -$161581.0 as the latest value for Q3 2025.

Quarterly Net Cash Flow fell 135.84% to -$161581.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $272428.0 through Sep 2025, down 78.45% year-over-year, with the annual reading at -$100265.0 for FY2024, 95.75% up from the prior year.
Net Cash Flow hit -$161581.0 in Q3 2025 for Bio Key International, up from -$917212.0 in the prior quarter.
In the past five years, Net Cash Flow ranged from a high of $2.7 million in Q1 2025 to a low of -$3.5 million in Q1 2021.
Historically, Net Cash Flow has averaged -$795378.5 across 5 years, with a median of -$828375.0 in 2022.
Biggest five-year swings in Net Cash Flow: plummeted 5189.67% in 2024 and later surged 1014.41% in 2025.
Year by year, Net Cash Flow stood at -$1.8 million in 2021, then skyrocketed by 90.89% to -$167490.0 in 2022, then soared by 115.7% to $26291.0 in 2023, then tumbled by 5189.67% to -$1.3 million in 2024, then skyrocketed by 87.92% to -$161581.0 in 2025.
Business Quant data shows Net Cash Flow for BKYI at -$161581.0 in Q3 2025, -$917212.0 in Q2 2025, and $2.7 million in Q1 2025.